Elanco Animal Health Inc
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
ELAN$26.76-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(in millions, except per-share data)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Revenue | $1,371 | $1,193 |
| Cost of sales | 586 | 509 |
| Gross profit | 785 | 684 |
| Research and development | 97 | 94 |
| Marketing, selling and administrative | 381 | 341 |
| Amortization of intangible assets | 138 | 128 |
| Asset impairment, restructuring and other special charges | 16 | 9 |
| Interest expense, net of capitalized interest | 57 | 40 |
| Other expense, net | 9 | 12 |
| Income before income taxes | 87 | 60 |
| Income tax expense (benefit) | 30 | (7) |
| Net income | $57 | $67 |
| Earnings per share: | ||
| Basic | $0.11 | $0.14 |
| Diluted | $0.11 | $0.13 |
| Weighted-average shares outstanding: | ||
| Basic | 497.7 | 495.1 |
| Diluted | 506.0 | 499.1 |
2026 Q1 Form 10-Q | 4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.